- Home
- RGNX vs INNV Comparison
RGNX vs INNV Comparison
Compare RGNX & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- INNV
- Stock Information
- Founded
- RGNX 2008
- INNV 2007
- Country
- RGNX United States
- INNV United States
- Employees
- RGNX N/A
- INNV N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- INNV Medical/Nursing Services
- Sector
- RGNX Health Care
- INNV Health Care
- Exchange
- RGNX Nasdaq
- INNV Nasdaq
- Market Cap
- RGNX 445.5M
- INNV 485.4M
- IPO Year
- RGNX 2015
- INNV 2021
- Fundamental
- Price
- RGNX $8.82
- INNV $3.96
- Analyst Decision
- RGNX Strong Buy
- INNV Sell
- Analyst Count
- RGNX 8
- INNV 2
- Target Price
- RGNX $28.50
- INNV $5.00
- AVG Volume (30 Days)
- RGNX 687.5K
- INNV 20.5K
- Earning Date
- RGNX 08-07-2025
- INNV 09-09-2025
- Dividend Yield
- RGNX N/A
- INNV N/A
- EPS Growth
- RGNX N/A
- INNV N/A
- EPS
- RGNX N/A
- INNV N/A
- Revenue
- RGNX $155,782,000.00
- INNV $831,683,000.00
- Revenue This Year
- RGNX $327.08
- INNV $13.77
- Revenue Next Year
- RGNX N/A
- INNV $10.12
- P/E Ratio
- RGNX N/A
- INNV N/A
- Revenue Growth
- RGNX 74.95
- INNV 12.19
- 52 Week Low
- RGNX $5.04
- INNV $2.60
- 52 Week High
- RGNX $13.48
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- RGNX 53.29
- INNV 59.25
- Support Level
- RGNX $7.83
- INNV $3.41
- Resistance Level
- RGNX $9.24
- INNV $3.88
- Average True Range (ATR)
- RGNX 0.51
- INNV 0.23
- MACD
- RGNX 0.08
- INNV 0.07
- Stochastic Oscillator
- RGNX 77.37
- INNV 87.71
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.